CCDC124
gene geneOn this page
Also known as Lso2oxs1
Summary
CCDC124 (coiled-coil domain containing 124, HGNC:25171) is a protein-coding gene on chromosome 19p13.11, encoding Coiled-coil domain-containing protein 124 (Q96CT7). Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage.
Enables RNA binding activity. Predicted to be involved in transcription by RNA polymerase II. Located in cytosol and plasma membrane.
Source: NCBI Gene 115098 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_001136203
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25171 |
| Approved symbol | CCDC124 |
| Name | coiled-coil domain containing 124 |
| Location | 19p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Lso2, oxs1 |
| Ensembl gene | ENSG00000007080 |
| Ensembl biotype | protein_coding |
| OMIM | 621286 |
| Entrez | 115098 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 21 protein_coding, 1 retained_intron
ENST00000445755, ENST00000596123, ENST00000597436, ENST00000602080, ENST00000873323, ENST00000873324, ENST00000873325, ENST00000873326, ENST00000873327, ENST00000926054, ENST00000926055, ENST00000926056, ENST00000926057, ENST00000926058, ENST00000926059, ENST00000926060, ENST00000926061, ENST00000926062, ENST00000926063, ENST00000926064, ENST00000926065, ENST00000944720
RefSeq mRNA: 2 — MANE Select: NM_001136203
NM_001136203, NM_138442
CCDS: CCDS12369
Canonical transcript exons
ENST00000445755 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000689900 | 17943261 | 17943375 |
| ENSE00001056262 | 17942656 | 17942845 |
| ENSE00001658662 | 17936410 | 17936579 |
| ENSE00001765913 | 17933015 | 17933048 |
| ENSE00003035563 | 17943508 | 17943985 |
Expression profiles
Bgee: expression breadth ubiquitous, 214 present calls, max score 97.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 34.4647 / max 209.8827, expressed in 1821 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174563 | 32.5623 | 1821 |
| 174564 | 1.9024 | 1081 |
Top tissues by expression
238 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| anterior cingulate cortex | UBERON:0009835 | 97.45 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.35 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.27 | gold quality |
| lower esophagus | UBERON:0013473 | 97.26 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.20 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 96.99 | gold quality |
| apex of heart | UBERON:0002098 | 96.96 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.90 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.88 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.78 | gold quality |
| left coronary artery | UBERON:0001626 | 96.77 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.76 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.64 | gold quality |
| muscle of leg | UBERON:0001383 | 96.60 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.51 | gold quality |
| popliteal artery | UBERON:0002250 | 96.50 | gold quality |
| tibial artery | UBERON:0007610 | 96.49 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.47 | gold quality |
| ascending aorta | UBERON:0001496 | 96.34 | gold quality |
| aorta | UBERON:0000947 | 96.32 | gold quality |
| thoracic aorta | UBERON:0001515 | 96.30 | gold quality |
| coronary artery | UBERON:0001621 | 96.15 | gold quality |
| amygdala | UBERON:0001876 | 96.10 | gold quality |
| right coronary artery | UBERON:0001625 | 96.08 | gold quality |
| skin of leg | UBERON:0001511 | 96.02 | gold quality |
| hypothalamus | UBERON:0001898 | 95.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.89 | gold quality |
| ectocervix | UBERON:0012249 | 95.82 | gold quality |
| esophagus | UBERON:0001043 | 95.79 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.17 |
| E-MTAB-7303 | no | 492.84 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting CCDC124, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-138-5P | 98.43 | 70.49 | 1292 |
| HSA-MIR-3661 | 97.83 | 67.30 | 705 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
Literature-anchored findings (GeneRIF, showing 5)
- Ccdc124 is a novel factor operating both for proper progression of late cytokinetic stages in eukaryotes. (PMID:23894443)
- Structure and function of yeast Lso2 and human CCDC124 bound to hibernating ribosomes. (PMID:32687489)
- Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers. (PMID:33896821)
- Dimerization underlies the aggregation propensity of intrinsically disordered coiled-coil domain-containing 124. (PMID:34369007)
- Live Cell Protein Imaging of Tandem Complemented-GFP11-Tagged Coiled-Coil Domain-Containing Protein-124 Identifies this Factor in G3BP1-Induced Stress-Granules. (PMID:39009911)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc124 | ENSDARG00000043502 |
| mus_musculus | Ccdc124 | ENSMUSG00000007721 |
| rattus_norvegicus | Ccdc124 | ENSRNOG00000018932 |
| drosophila_melanogaster | CG6013 | FBGN0038675 |
| caenorhabditis_elegans | Y73E7A.1 | WBGENE00022268 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 124 — Q96CT7 (reviewed: Q96CT7)
All UniProt accessions (2): Q96CT7, M0R2F5
UniProt curated annotations — full annotation on UniProt →
Function. Ribosome-binding protein involved in ribosome hibernation: associates with translationally inactive ribosomes and stabilizes the nonrotated conformation of the 80S ribosome, thereby promoting ribosome preservation and storage. Also required for proper progression of late cytokinetic stages.
Subunit / interactions. Associates with translationally inactive ribosomes in the nonrotated state. Interacts with RASGEF1B.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Midbody.
Tissue specificity. Ubiquitously expressed.
Similarity. Belongs to the CCDC124 family.
RefSeq proteins (2): NP_001129675, NP_612451 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010422 | Ccdc124/Oxs1 | Family |
| IPR054414 | Ccdc124/Oxs1_C | Domain |
Pfam: PF06244
UniProt features (9 total): region of interest 2, compositionally biased region 2, modified residue 2, chain 1, coiled-coil region 1, sequence variant 1
Structure
Experimental structures (PDB)
7 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8K2C | ELECTRON MICROSCOPY | 2.4 |
| 6ZM7 | ELECTRON MICROSCOPY | 2.7 |
| 9P9H | ELECTRON MICROSCOPY | 2.84 |
| 6Z6L | ELECTRON MICROSCOPY | 3 |
| 6ZME | ELECTRON MICROSCOPY | 3 |
| 8XSY | ELECTRON MICROSCOPY | 3 |
| 9B0J |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96CT7-F1 | 80.59 | 0.33 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 141, 194
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 85 (showing top):
GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, GOBP_CELL_DIVISION, GOCC_MIDBODY, chr19p13, GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, BRUINS_UVC_RESPONSE_EARLY_LATE, DELACROIX_RARG_BOUND_MEF, GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY, MYC_UP.V1_UP, CAMP_UP.V1_UP, GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY
GO Biological Process (3): transcription by RNA polymerase II (GO:0006366), cell division (GO:0051301), positive regulation of DNA-templated transcription (GO:0045893)
GO Molecular Function (3): transcription coactivator activity (GO:0003713), RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (7): nucleus (GO:0005634), centrosome (GO:0005813), cytosol (GO:0005829), plasma membrane (GO:0005886), midbody (GO:0030496), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| DNA-templated transcription | 2 |
| cellular process | 1 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| transcription coregulator activity | 1 |
| positive regulation of DNA-templated transcription | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1381 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC124 | C5orf34 | Q96MH7 | 749 |
| CCDC124 | HAAO | P46952 | 669 |
| CCDC124 | COPS8 | Q99627 | 665 |
| CCDC124 | IFRD2 | Q12894 | 508 |
| CCDC124 | RDH12 | Q96NR8 | 506 |
| CCDC124 | SERBP1 | Q8NC51 | 490 |
| CCDC124 | C19orf53 | Q9UNZ5 | 481 |
| CCDC124 | PPIAL4D | F5H284 | 466 |
| CCDC124 | EML3 | Q32P44 | 459 |
| CCDC124 | PIK3R5 | Q8WYR1 | 449 |
| CCDC124 | CCDC77 | Q9BR77 | 441 |
| CCDC124 | TRIM64B | A6NI03 | 434 |
| CCDC124 | AURKAIP1 | Q9NWT8 | 432 |
| CCDC124 | P4HB | P07237 | 428 |
| CCDC124 | EIF3J | O75822 | 426 |
IntAct
92 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NPM1 | CCDC124 | psi-mi:“MI:0403”(colocalization) | 0.650 |
| CCDC124 | NPM1 | psi-mi:“MI:0914”(association) | 0.650 |
| NPM1 | CCDC124 | psi-mi:“MI:0915”(physical association) | 0.650 |
| ABCE1 | EIF3H | psi-mi:“MI:0914”(association) | 0.530 |
| CHLSN | RPL14 | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC124 | MYH9 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC124 | H1-1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC124 | H2BC9 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CD81 | HIP1R | psi-mi:“MI:0914”(association) | 0.350 |
| Rpl35 | RPS6 | psi-mi:“MI:0914”(association) | 0.350 |
| Bcas2 | PEX10 | psi-mi:“MI:0914”(association) | 0.350 |
| Pcgf1 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL10 | RPS6 | psi-mi:“MI:0914”(association) | 0.350 |
| BCOR | HSPD1 | psi-mi:“MI:0914”(association) | 0.350 |
| Srp72 | psi-mi:“MI:0914”(association) | 0.350 | |
| Rrbp1 | PIPSL | psi-mi:“MI:0914”(association) | 0.350 |
| NOP56 | C12orf43 | psi-mi:“MI:0914”(association) | 0.350 |
| XRCC3 | DERL1 | psi-mi:“MI:0914”(association) | 0.350 |
| EMC2 | TBL2 | psi-mi:“MI:0914”(association) | 0.350 |
| MMGT1 | DERL1 | psi-mi:“MI:0914”(association) | 0.350 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| NP | HNRNPAB | psi-mi:“MI:0914”(association) | 0.350 |
| BCAR1 | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| DLD | NFKBIE | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | MEX3A | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (148): CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Proximity Label-MS), CCDC124 (Proximity Label-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS), CCDC124 (Affinity Capture-MS)
ESM2 similar proteins: A5JSS4, B1MTI8, O88892, P02641, P06398, P09739, P0C0A9, P12620, P45378, P84101, P84102, Q05310, Q0UVD1, Q148I0, Q1E554, Q28HN4, Q28IN9, Q2KIT1, Q2TBR9, Q2TBV6, Q32P76, Q3E7B7, Q4I5Z5, Q5R5J3, Q5R6N0, Q5R7C4, Q5R8X8, Q5REM2, Q5ZHK9, Q68EY7, Q6DD17, Q6GNG8, Q6NVR5, Q6PHE8, Q75NG9, Q7SDA6, Q7ZY35, Q8MKI3, Q8NHG7, Q8R1F0
Diamond homologs: O94389, Q28HN4, Q2TBV6, Q54GW3, Q5R8X8, Q68EY7, Q6DD17, Q6PHE8, Q96CT7, Q9D8X2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 117 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| SRP-dependent cotranslational protein targeting to membrane | 16 | 19.1× | 6e-14 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 12 | 17.9× | 2e-10 |
| Formation of a pool of free 40S subunits | 13 | 17.3× | 1e-10 |
| Peptide chain elongation | 11 | 16.6× | 3e-09 |
| Viral mRNA Translation | 11 | 16.6× | 3e-09 |
| Selenocysteine synthesis | 11 | 15.7× | 4e-09 |
| Eukaryotic Translation Termination | 11 | 15.7× | 4e-09 |
| L13a-mediated translational silencing of Ceruloplasmin expression | 13 | 15.6× | 2e-10 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 13 | 23.8× | 6e-12 |
| translational initiation | 5 | 17.8× | 1e-03 |
| ribosomal small subunit biogenesis | 7 | 15.8× | 8e-05 |
| translation | 13 | 13.2× | 7e-09 |
| rRNA processing | 7 | 9.8× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
863 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:17936408:A:AG | acceptor_gain | 1.0000 |
| 19:17936409:G:GG | acceptor_gain | 1.0000 |
| 19:17936409:GCCT:G | acceptor_gain | 1.0000 |
| 19:17936564:G:GT | donor_gain | 1.0000 |
| 19:17936580:G:GG | donor_gain | 1.0000 |
| 19:17942654:A:AG | acceptor_gain | 1.0000 |
| 19:17942654:AGGAG:A | acceptor_gain | 1.0000 |
| 19:17942655:G:GT | acceptor_gain | 1.0000 |
| 19:17942655:GGA:G | acceptor_gain | 1.0000 |
| 19:17942655:GGAGG:G | acceptor_gain | 1.0000 |
| 19:17942824:C:G | donor_gain | 1.0000 |
| 19:17942829:G:GT | donor_gain | 1.0000 |
| 19:17942830:G:GT | donor_gain | 1.0000 |
| 19:17942830:G:T | donor_gain | 1.0000 |
| 19:17942899:GACCT:G | donor_gain | 1.0000 |
| 19:17943233:T:TA | acceptor_gain | 1.0000 |
| 19:17943239:T:TA | acceptor_gain | 1.0000 |
| 19:17943243:A:AG | acceptor_gain | 1.0000 |
| 19:17943244:C:G | acceptor_gain | 1.0000 |
| 19:17943247:A:AG | acceptor_gain | 1.0000 |
| 19:17943248:C:G | acceptor_gain | 1.0000 |
| 19:17943251:A:AG | acceptor_gain | 1.0000 |
| 19:17943251:ACCC:A | acceptor_gain | 1.0000 |
| 19:17943252:C:G | acceptor_gain | 1.0000 |
| 19:17943254:C:CA | acceptor_gain | 1.0000 |
| 19:17943256:CCCA:C | acceptor_loss | 1.0000 |
| 19:17943258:CA:C | acceptor_loss | 1.0000 |
| 19:17943259:A:AC | acceptor_loss | 1.0000 |
| 19:17943259:A:AG | acceptor_gain | 1.0000 |
| 19:17943259:AGCC:A | acceptor_gain | 1.0000 |
AlphaMissense
1461 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:17943630:T:C | L196P | 0.999 |
| 19:17943653:T:A | W204R | 0.999 |
| 19:17943653:T:C | W204R | 0.999 |
| 19:17936453:G:C | K11N | 0.998 |
| 19:17936453:G:T | K11N | 0.998 |
| 19:17943359:G:C | A150P | 0.998 |
| 19:17943598:A:C | K185N | 0.998 |
| 19:17943598:A:T | K185N | 0.998 |
| 19:17943655:G:C | W204C | 0.998 |
| 19:17943655:G:T | W204C | 0.998 |
| 19:17936575:G:C | R52P | 0.997 |
| 19:17943360:C:A | A150D | 0.997 |
| 19:17943363:T:A | I151N | 0.997 |
| 19:17943569:T:C | F176L | 0.997 |
| 19:17943571:T:A | F176L | 0.997 |
| 19:17943571:T:G | F176L | 0.997 |
| 19:17943642:T:C | L200P | 0.997 |
| 19:17943654:G:C | W204S | 0.997 |
| 19:17943673:C:A | N210K | 0.997 |
| 19:17943673:C:G | N210K | 0.997 |
| 19:17936447:C:A | N9K | 0.996 |
| 19:17936447:C:G | N9K | 0.996 |
| 19:17936451:A:G | K11E | 0.996 |
| 19:17936464:C:A | A15D | 0.996 |
| 19:17936469:G:C | A17P | 0.996 |
| 19:17936535:T:A | W39R | 0.996 |
| 19:17936535:T:C | W39R | 0.996 |
| 19:17936537:G:C | W39C | 0.996 |
| 19:17936537:G:T | W39C | 0.996 |
| 19:17936574:C:A | R52S | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000150866 (19:17933451 C>G,T), RS1000286032 (19:17939107 G>A), RS1000347128 (19:17943969 A>G), RS1000471513 (19:17934603 T>C), RS1000478939 (19:17943872 C>T), RS1000686330 (19:17942927 C>A,G), RS1001030424 (19:17938584 T>C), RS1001263430 (19:17935041 A>C), RS1001495123 (19:17940488 C>T), RS1001793598 (19:17938685 G>A,C), RS1001878351 (19:17934927 C>A,G,T), RS1002225188 (19:17932969 T>C), RS1002270708 (19:17933730 A>G), RS1002277506 (19:17933088 G>A,T), RS1002488638 (19:17941467 G>A)
Disease associations
OMIM: gene MIM:621286 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002385_505 | High light scatter reticulocyte count | 6.000000e-13 |
| GCST90002385_506 | High light scatter reticulocyte count | 3.000000e-11 |
| GCST90002386_201 | High light scatter reticulocyte percentage of red cells | 4.000000e-11 |
| GCST90002386_75 | High light scatter reticulocyte percentage of red cells | 1.000000e-12 |
| GCST90002387_48 | Immature fraction of reticulocytes | 1.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| bisphenol A | decreases methylation, increases expression | 2 |
| Caffeine | decreases phosphorylation, increases expression | 2 |
| Valproic Acid | increases expression, increases methylation | 2 |
| Particulate Matter | increases abundance, decreases expression, decreases reaction | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | increases expression | 1 |
| beauvericin | decreases expression | 1 |
| pyrogallol 1,3-dimethyl ether | affects cotreatment, decreases expression, affects localization, increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression, decreases reaction | 1 |
| bisphenol AF | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Vehicle Emissions | decreases expression, decreases reaction | 1 |
| Furaldehyde | increases expression, affects cotreatment, decreases expression, affects localization | 1 |
| Ivermectin | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Sodium Chloride | affects localization, increases expression, affects cotreatment, decreases expression | 1 |
| Dronabinol | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.